相关实验视频

Updated: Sep 11, 2025

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

免疫分层在HPV阴性HNSCC:预后意义和免疫疗法反应的预测

Shuai Xu¹, Yangfan Lv², HaiTao He³

¹Institute of Immunology, Third Military Medical University (Army Medical University), Chongqing 400038, People's Republic of China; Department of Head and Neck Surgery, The Second Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, People's Republic of China.

|August 16, 2025

概括

瘤免疫微环境 (TIME) 中的三级淋巴体结构 (TLS) 改善了头部和部状细胞癌 (HNSCC) 的存活率和免疫治疗反应. 基于TLS的免疫分层提供了比HPV阴性HNSCC的传统分期更好的预后预测.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

瘤免疫微环境 (TIME) 显著影响头部和部状细胞癌 (HNSCC) 的进展和治疗结果.
了解TIME异质性对于开发有效的免疫疗法至关重要.

研究的目的:

在HNSCC.中识别不同的TIME表型.
评估三级淋巴体结构 (TLS) 在HPV阴性HNSCC的预后和预测价值.
为个性化治疗策略开发免疫分层系统.

主要方法:

来自TCGA和GEO数据库的基因表达特征分析 (n=790个HNSCC瘤).
识别了五种基于时间的表型,包括TLS特征的E类.
在HPV阴性HNSCC队列 (手术和免疫治疗患者) 中验证TLS预后值.
临床和转录基因数据的整合用于免疫分层.

主要成果:

确定了五种不同的TIME表型,其中TLS阳性E类显示出更高的生存率和免疫治疗反应.
具有TLS阳性状态与HPV阴性HNSCC的显著更好的生存率和增强的免疫疗法反应有关.
综合 TIME 和免疫细胞计数的免疫分层系统在预测整体存活率方面比 TNM 阶段计数更准确.

结论:

三级淋巴体结构 (TLS) 是HPV阴性HNSCC的显著预后和预测生物标志物.
基于TLS的免疫分层系统为个性化治疗和改善患者结果提供了强大的框架.
这些发现支持将TLS评估纳入HNSCC管理的临床实践.

关键词:

头部和部状细胞癌瘤免疫分类免疫分类免疫治疗是一种免疫疗法.预测生物标志物预测生物标志物三级淋巴体结构的第三级淋巴体结构.免疫瘤的微环境

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...